azomycin has been researched along with zithromax in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Admour, I; Dham, R; Ghanem, IE; Idkaidek, N; Mahmood Alam, S; Najib, NM; Zaman, Q | 1 |
Rossignol, JF | 1 |
Duarte, RV; Franik, S; Fuhrich, DG; Ross, J; Savaris, RF | 1 |
Jo, KW; Nam, GB; Shim, TS; Yoon, HY | 1 |
Duarte, RV; Fuhrich, DG; Maissiat, J; Ross, J; Savaris, RF | 1 |
2 review(s) available for azomycin and zithromax
Article | Year |
---|---|
Antibiotic therapy for pelvic inflammatory disease.
Topics: Adolescent; Adult; Aminoglycosides; Anti-Bacterial Agents; Azithromycin; Cephalosporins; Clindamycin; Doxycycline; Female; Humans; Nitroimidazoles; Pelvic Inflammatory Disease; Publication Bias; Quinolones; Randomized Controlled Trials as Topic | 2017 |
Antibiotic therapy for pelvic inflammatory disease.
Topics: Adolescent; Adult; Aminoglycosides; Anti-Bacterial Agents; Azithromycin; Cephalosporins; Clindamycin; Doxycycline; Drug Therapy, Combination; Female; Humans; Nitroimidazoles; Pelvic Inflammatory Disease; Publication Bias; Quinolones; Randomized Controlled Trials as Topic | 2020 |
3 other study(ies) available for azomycin and zithromax
Article | Year |
---|---|
Bioequivalence assessment of Azomycin (Julphar, UAE) as compared to Zithromax (Pfizer, USA)--two brands of azithromycin--in healthy human volunteers.
Topics: Administration, Oral; Adolescent; Adult; Analysis of Variance; Anti-Bacterial Agents; Area Under Curve; Azithromycin; Chemistry, Pharmaceutical; Confidence Intervals; Humans; Male; Nitroimidazoles; Therapeutic Equivalency | 2001 |
Cryptosporidium and Giardia: treatment options and prospects for new drugs.
Topics: AIDS-Related Opportunistic Infections; Antibodies, Monoclonal; Antiparasitic Agents; Antiretroviral Therapy, Highly Active; Azithromycin; Benzimidazoles; Cryptosporidiosis; Giardia lamblia; Giardiasis; Humans; Nitro Compounds; Nitroimidazoles; Paromomycin; Roxithromycin; Thiazoles | 2010 |
Clinical significance of QT-prolonging drug use in patients with MDR-TB or NTM disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Azithromycin; Child; Clarithromycin; Clofazimine; Diarylquinolines; Female; Fluoroquinolones; Follow-Up Studies; Humans; Lost to Follow-Up; Macrolides; Male; Middle Aged; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nitroimidazoles; Nontuberculous Mycobacteria; Oxazoles; Retrospective Studies; Tuberculosis, Multidrug-Resistant; Young Adult | 2017 |